Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	57.11	171.51	109.17
Graham Fair Price	-3.02	14598.82	15053.64
PEG	178.72	0.06	-0.02
Price/Book	25.62	0.38	0.31
Price/Cash Flow	-21.58	1.25	1.59
Prices/Earnings	-21.72	1.11	1.41
Price/Sales	2.42	0.37	0.37
Price/FCF	-21.58	1.25	1.59
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-152.38	< 0.005	< 0.005
ROA	17.38	< 0.005	< 0.005
ROE	0.05	0.09	60.48
ROIC	< 0.005	< 0.005	-250.34
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	-0.18	-99.74
Dividends QOQ	-0.58	1.37	136.91
EBIT QOQ	1.00	-1.37	37.14
EPS QOQ	-0.64	0.18	-71.91
FCF QOQ	0.12	0.23	95.78
Revenue QOQ	0.05	-0.06	26.37
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.33	0.39	18.77
Quick Ratio	< 0.005	5.00	57983.70
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	13638.07	10440.60	-23.45
Cash	1313.45	1864.31	41.94
Capex	-32.15	59.79	85.98
Free Cash Flow	2620.59	3213.52	22.63
Revenue	11418.30	10721.21	-6.10
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.03	5.00	18430.64
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	62.01	94.64	52.61
Naive Interpretation	Member

06 - Financial Health · Bad

Rating